[1]
2025. Early Phase Trial Participation Among Under-Served Groups: Barriers Measured at Screening. Translational Medicine & Therapeutics Journal. 4, 1 (May 2025), 37–45. DOI:https://doi.org/10.5281/zenodo.22649341.